Survisors of childhood cancer run a greater risk of developing health problems relating to their treatment with chemotherapy. These problems, knows as late effects, may not become evident until many years after treatment and can significantly impair survivors’ quality of life, which is why screening is necessary for this group. In the Netherlands, a task force was established to carry out the follow-up care for childhood cancer survivors. Ellen Kilsdonk evaluates the guidelines developed by this task force, as well as the strategies aimed at achieving optimal participation rates in questionnaire studies among supervisors of childhood cancer.
E. Kilsdonk: Long-Term Follow-up of Childhood Cancer Survivors: Clinical Decision Support and Research Participation.
Prof. F.E. van Leeuwen
Prof. M.W.M. Jaspers
Dr E. van Dulmen-den Broeder
Dr M.H. van den Berg
This event is open to the public.